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Edited by Hans-Dieter KlenkAbstract Nucleoside analogs (NAs) are an important class of
anti-retroviral compounds used against human immunodeﬁciency
virus (HIV). We have analyzed the potential eﬀect of polyamines
on the incorporation of NAs during DNA synthesis by HIV type-
1 (HIV-1) reverse transcriptase (RT). The polyamines exert the
ability to decrease the incorporation of various dideoxynucleo-
side triphosphates (ddATP, ddTTP or ddCTP) with both
RNA/DNA and DNA/DNA substrates in the following order:
spermine > spermidine > putrescine. The reduction is a se-
quence-independent eﬀect, taking place at diﬀerent sequence con-
text. The results suggest that polyamines might aﬀect the
inhibition of reverse transcription by nucleoside analogs HIV-1
RT directed.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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analogs; DNA synthesis; Polyamines1. Introduction
The reverse transcriptase (RT), a key enzyme in the life cycle
of the human immunodeﬁciency virus type 1 (HIV-1), was
found to be a successful target for the treatment of AIDS
[1]. HIV-1 RT is multifunctional enzyme, exhibiting several
enzymatic activities by a single polypeptide. The enzyme cata-
lyzes the transcription of the viral genomic single-stranded
RNA into the double-stranded DNA in the cytoplasm by
two DNA polymerase activities, RNA-dependent DNA poly-
merase (like cellular enzymes) and RNA-dependent DNA
polymerase (unlike cellular enzymes) [2]. The enzyme carries
out error-prone DNA synthesis, since it lacks an intrinsic
3 0 ﬁ 5 0 proofreading exonuclease activity and copies RNA
with low ﬁdelity during both RNAﬁ DNA and DNAﬁ D-
NA replication steps, thus contributing to mutagenesis [3–7].Abbreviations: RT, reverse transcriptase; HIV-1, human immunodeﬁ-
ciency virus type-1; NRTI, nucleoside RT inhibitors; NA, nucleoside
analogs; DDDP, DNA-dependent DNA polymerization; RDDP,
RNA-dependent DNA polymerization
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doi:10.1016/j.febslet.2006.08.074The high error rates of HIV-1 RT can be attributed to eﬃcient
misinsertion and extension of mispaired nucleotides during the
RNA- and DNA-dependent DNA polymerization steps. HIV-
1 RT readily utilizes many nucleoside analogs (NA’s) of the
normal deoxynucleoside triphosphate (dNTP) substrates [8].
NAs, upon entering the cell are converted into their triphos-
phates by cellular kinases and subsequently incorporated into
DNA during replication [9,10]. The antiviral activity of NA is
attributed to the preferential incorporation of their triphos-
phate forms into the 3 0-end of viral DNA by RT leading to
premature termination of DNA polymerization. The nucleo-
side RT inhibitors (NRTIs), representing one of the major
classes of anti-HIV drugs, are incorporated into the nascent
viral DNA by HIV-1 RT, inducing chain termination because
they lack a 3 0 hydroxyl group [8]. Although NRTIs reduce vir-
al load in HIV-1 infected individuals, the eﬀectiveness of NRTI
therapy is limited by the rapid emergence of drug-resistant RT
[11]. Mutations that arise in the pol gene of HIV (that encodes
the RT) lead to the synthesis of RT that retain full catalytic
activities, yet is highly resistant to anti-retroviral drugs [8].
The conditions during intracellular proviral dsDNA synthe-
sis in vivo are complex. The accuracy of reverse transcription,
its inhibition by NRTIs and resistance to this inhibition might
be inﬂuenced by the physiological microenvironments and by
cellular and/or viral factors/proteins involved in the reverse
transcription complex. The accessory proteins/factors that
comprise the retrovirus replication complex can interact with
the viral nucleic acid, or with HIV-1 RT and/or other acces-
sory proteins. Our recent studies showed that polyamines
may aﬀect the eﬃciency and speciﬁcity of mispair formation
[12]. Polyamines exert the ability to reduce the misincorpora-
tion and mispair extension by HIV-1 RT with both RNA/
DNA and DNA/DNA template-primers.
Polyamines are essential for cell growth. The polyamines
putrescine, spermidine and spermine, present in all living cells,
are low molecular weight aliphatic molecules that participate
in many cellular processes by binding and modulating the func-
tions ofRNA,DNAdNTPs and proteins [13–15]. Their concen-
trations in cells are cell-cycle dependent [16]. The polyamines
have been demonstrated to potently interact with various nu-
cleic acids [17] and are probably involved in transcription and
translation of geneticmaterial. The polyamines have been impli-
cated in the replication of some herpesviruses and retroviruses.
The cells infected with a number of viruses (e.g. HSV-1, human
cytomegalovirus) have high levels of the polyamines [18,19].
Lymphocytes from patients infected with HIV-1 also haveation of European Biochemical Societies.
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ine and spermidine are integral parts of HIV virions; polyamine
incorporation into virions may be important for folding and/or
packaging of viral RNA or it may mediate the interaction
between viral RNA and the tRNAlys primer.
The observation that HIV-1 RT in the presence of poly-
amines has an enhanced ﬁdelity of DNA synthesis, prompted
us to study the eﬀect of polyamines on the incorporation of
nucleoside analogs during DNA synthesis by HIV-1 RT. Our
results demonstrate that polyamines exert the ability to reduce
the incorporation of various dideoxynucleoside triphosphates
tested (e.g. ddATP, ddTTP or ddCTP) with both RNA/
DNA and DNA/DNA template-primers. The data suggest that
polyamines represent the cellular component that may have an
impact on the development of resistance to NRTIs.2. Materials and methods
2.1. Materials
The HIV-1 RT was the puriﬁed recombinant enzyme expressed in
Escherichia coli from BH-10 proviral clone [21,22]. The speciﬁc activity
of the enzyme was 4000–5000 U/lg. One unit was deﬁned as the
amount of enzyme that catalyzes the incorporation of 1 pmol of dTMP
into DNA in the poly(rA)n Æ oligo(dT)1218-directed reaction in 30 min
at 37 C. T4 polynucleotide kinase was purchased from MBI (Fermen-
tas). The dNTPs and ddNTPs used were of the highest purity available
(MBI Fermentas) with no detectable traces of contamination by other
dNTPs and ddNTPs.
2.2. Template-primers
The template-primer substrates used for assessing the incorporation
of various NA’s have been previously described [6,23]. Four template-
primer substrates were used for the analysis of the incorporation of
various dideoxynucleoside triphosphates during the DNA synthesis
by HIV-1 RT. The ribosomal RNA (rRNA) (a mixture of 16S and
23S E. coli rRNA), as a native substrate, was primed with 16-mer oli-
gonucleotide primers, that hybridizes to the nucleotides at positions
2012–2027 of the 16S rRNA (the sequence of the primer is 5 0-ATT-
TCACATCTGACTT-30) or that hybridizes to the nucleotides at posi-
tions 2014–2029 of the 16S rRNA (the sequence of the primer is 5 0-
GGATTTCACATCTGAC-3 0). The (N)30 synthetic oligonucleotide
DNA template identical to nucleotides 2000–2029 of E. coli 16S rRNA
(5 0-AGGCGGTTTGTTAAGTCAGATGTGAAATCC-3 0), was
primed with an (N)16 oligonucleotides, (utilized with rRNA template)
that hybridizes to the nucleotides at positions 13–28 of the template
DNA (5 0-ATTTCACATCTGACTT-3 0) or that hybridizes to the
nucleotides at positions 15–30 of the template DNA (5 0-
GGATTTCACATCTGAC-3 0). The primers were end labeled at the
5 0-end with T4 polynucleotide kinase and [c32P] ATP. Unincorporated
radioactivity was removed by using G-25 microspin columns (Pharma-
cia Biotech.), according to the instructions of the manufacturer. The
end-labeled primers were annealed to the template RNA or DNA as
described [6,23].
2.3. DNA polymerization reaction
The incubation mixture (10 ll) contained 50 mM Tris HCl (pH 7.5),
5 mM MgCl2, 1 mM DTT, 0.1 mg/ml BSA, 5
0-end labeled substrates
and nucleoside analog. The reaction products of NA incorporation
were analyzed by electrophoresis through 16% PAGE, as described
[5,6]. Extension of the 5 0-end labeled primers was detected by autora-
diography. The extension products were quantiﬁed by densitometric
scanning of gel autoradiographs and the percentage of the total
amounts of primers extended was calculated.
2.4. The gel retardation assay
Complex formation between the oligonucleotide DNA and HIV-1
RT was characterized by the electrophoretic retardation of DNA as
a result of its association with the enzyme. The binding reaction assays
were conducted as described previously [24].3. Results
The incorporation of NA into the 3 0-end of DNA is impor-
tant for antiviral activity. The reduction in incorporation of
the dideoxynucleoside triphosphates in DNA may decrease
their potential for chain termination. Reverse transcription in-
volves the synthesis of DNA using RNA and DNA templates
to convert the plus strand genomic RNA into dsDNA [2].
Hence, it was of interest to elucidate the role of various poly-
amines in the incorporation of diﬀerent NAs by HIV-1 RT
during double-stranded DNA synthesis.
3.1. The incorporation of various nucleoside analogs by HIV-1
RT in the presence of polyamines
The incorporation of nucleoside analogs by HIV-1 RT was
assessed with deﬁned substrates in the absence or presence of
5 mM polyamines – putrescine, spermidine and spermine,
using correctly-paired DNA/DNA and RNA/DNA running-
start template-primers at a ﬁxed concentration of 1.0 mM of
dATP and ddCTP, allowing the extension of the 16mer pri-
mer. The results of the primer extension assays show that
HIV-1 RT displays NA incorporation activity incorporating
ddCTP opposite the template G at site 10 of template DNA
(Fig. 1A, lane 1) or at site 2009 of template RNA (Fig. 1B lane
1) following the initial incorporation of two running-start A’s
prior to reaching the template target site G. Interestingly, the
incorporation of ddCTP was reduced in the presence of the
polyamines tested (Fig. 1A and B, lanes 2–4). Indeed, the
decrease in the amount of the 19mer product was detected.
We observed that the pattern of reduction in the presence of
polyamines was diﬀerent; spermine prevented most eﬃciently
the incorporation of ddCTP by HIV-1 RT (Fig. 1A and B,
lane 2).
The inﬂuence of the polyamines on the incorporation of
dideoxynucleoside triphosphates by HIV-1 RT was further
examined with two diﬀerent DNA/DNA and RNA/DNA
standing-start template-primers (wherein the target template
residue immediately follows the 3 0-terminal end of the primer),
at a ﬁxed concentration of 1 mM of ddATP (with substrate set
I) or ddTTP (with substrate set II), in the absence or presence
of 5 mM of spermine, spermidine or putrescine. Apparently,
RT readily incorporates NAs; the 17-mer product is accumu-
lated following the incorporation of ddATP opposite the tem-
plate T at site 12 of template DNA (set I) (Fig. 1A, lane 5) or
opposite template U at site 2011 of template RNA (set I)
(Fig. 1B, lane 5) or following the incorporation of ddTTP
opposite the template A at site 14 of template DNA (set II)
(Fig. 1A, lane 9) or opposite template A at site 2013 (set II)
(Fig. 1B, lane 9) by HIV-1 RT. However, the incorporation
of either ddATP or ddTTP was reduced in the presence of
the polyamines tested (Fig. 1A and B, lanes 6–8 and 10–12,
respectively), during both DDDP and RDDP reactions. The
decrease in the amount of 17mer products was detected. As
with running-start substrate, the propensity of the polyamines
to aﬀect the NA incorporation capacity of HIV-1 RT, was
most pronounced for spermine (Fig. 1A and B, lanes 6 and 10).
The experiments described in Fig. 1A and B, depict that
HIV-1 RT with both DNA/DNA and RNA/DNA template-
primers exerts lower capacity of incorporation of all dideoxy-
nucleoside triphosphates tested in the presence of polyamines,
suggesting that there is no diﬀerence in the nucleic acid nature
(RNA vs DNA) of the template.
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Fig. 1. Incorporation of various nucleoside analogs by HIV-1 RT. (A) The DNA/DNA template-primer (set I) was incubated with HIV-1 RT, 1 mM
dATP and ddCTP in the absence (lane 1) or presence of 5 mM of spermine (lane 2), spermidine (lane 3) or putrescine (lane 4). The DNA/DNA
template-primer (set I) was incubated with HIV-1 RT and 1 mM ddATP in the absence (lane 5) or presence of 5 mM of spermine (lane 6), spermidine
(lane 7) or putrescine (lane 8). The DNA/DNA template-primer (set II) was incubated with HIV-1 RT and 1 mM ddTTP in the absence (lane 9) or
presence of 5 mM of spermine (lane 10), spermidine (lane 11) or putrescine (lane 12). (B) The RNA/DNA template-primer (set I) was incubated with
HIV-1 RT, dATP and ddCTP in the absence (lane 1) or presence of 5 mM of spermine (lane 2), spermidine (lane 3) or putrescine (lane 4). The RNA/
DNA template-primer (set I) was incubated with HIV-1 RT and ddATP in the absence (lane 5) or presence of 5 mM of spermine (lane 6), spermidine
(lane 7) or putrescine (lane 8). The RNA/DNA template-primer (set II) was incubated with HIV-1 RT and ddTTP in the absence (lane 9) or presence
of 5 mM of spermine (lane 10), spermidine (lane 11) or putrescine (lane 12). The positions of the primers are indicated by arrows.
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triphosphates by HIV-1 RT in the presence of polyamines
The above experiments provide a qualitative indication of
the incorporation of dideoxynucleoside triphosphates byHIV-1 RT in the absence and presence of polyamines. Since,
a comparable pattern of reduction in the incorporation of
dideoxynucleoside triphosphates was observed with both
DNA and RNA templates used in the presence of all three
Spm:        - - - - - - - - - +          +             +            +
Put:         - +        +        +        +         - - - - - - - -
Spd:        - - - - - +          +          +         +         - - - -
Lanes:       1        2        3        4        5         6    7          8         9       10         11           12  13
16mer
5’-p32 ATT  TCA  CAT  CTG  ACT  T   -3’
3’ -CC TAA  AGT  GTA  GAC  TGA  ATT GTTTGG CGG A -5’
16mer
Lanes:      1          2          3         4           5       6          7           8          9        10       11      12 13
Spm:      - - - - - - - - - +         +        +         +
Put:       - +          +         +          +          - - - - - - - -
Spd:      - - - - - +          +          +          +         - - - -
Fig. 2. Incorporation of nucleoside analogs by HIV-1 RT in the presence of various concentrations of polyamines with DNA/DNA template-
primers. (A) The running-start substrate was incubated with HIV-1 RT, dATP and ddCTP in the absence (lane 1) or presence of various
concentrations of putrescine (lanes 2–5), spermidine (lanes 6–9) or spermine (lanes 10-13). Lanes 2, 6 and 10-with 1 mM polyamines. Lanes 3, 7 and
11-with 2 mM polyamines. Lanes 4, 8 and 12-with 5 mM polyamines. Lanes 5, 9 and 13-with 10 mM polyamines. (B) The standing-start substrate
was incubated with HIV-1 RT and ddATP in the absence (lane 1) or presence of various concentrations of putrescine (lanes 2–5), spermidine (lanes
6–9) or spermine (lanes 10–13). Lanes 2, 6 and 10 – with 1 mM polyamines. Lanes 3, 7 and 11– with 2 mM polyamines. Lanes 4, 8 and 12-with 5 mM
polyamines. Lanes 5, 9 and 13– with 10 mM polyamines. The position of the 16mer primer is indicated by arrow.
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further quantitative comparisons. The eﬃciency of incorpora-
tion of dideoxynucleoside triphosphates by HIV-1 RT with
both running-start and standing-start substrates was examined
in the presence of various concentrations of putrescine, spermi-
dine or spermine. The results obtained illustrate that the poly-
amines tested – putrescine, spermidine and spermine, cause a
concentration – dependent decrease in the incorporation
capacity of HIV-1 RT of ddCTP (with running-start tem-
plate-primer) (Fig. 2A, lanes 2–13) and of ddATP (with stand-
ing-start template-primer) (Fig. 2B, lanes 2–13); although the
pattern of reduction was diﬀerent. The inhibitory eﬀects were
found for concentrations of spermine or spermidine higher
than 1 mM and of putrescine higher than 5 mM.
To further characterize the inﬂuence of spermine on the
incorporation of nucleoside analogs by HIV-1 RT, we have
employed an assay that measures site-speciﬁc dideoxynucleo-
side triphosphates incorporation. We carried out a dose re-
sponse experiments using standing-start template-primers for
investigation of the kinetic parameters governing the incorpo-
ration frequency by HIV-1 RT in the absence or presence of
5 mM spermine. The rate of insertion of ddATP was examined
opposite the template T residue at position 12 of template
DNA (Fig. 3) and of ddTTP opposite the template A at site14 of template DNA (Fig. 4). The quantitation of the primer
extension bands resolved by PAGE provides a clear indication
of the ability of HIV-1 RT to insert dideoxynucleoside triphos-
phates. Kinetics of incorporation showed that the intensity of
the bands corresponding to ddATP or ddTTP-terminated
DNA molecules increases as a function of ddATP or ddTTP
concentrations (Figs. 3 and 4, respectively). However, the
intensity of the ddATP or ddTTP-terminated products
strongly decreased in the presence of spermine. We have mea-
sured the ratios of gel band intensities, estimated by densitom-
etry and determined the extension rates (V = percentage of
primer extended) as a function of ddATP or ddTTP concentra-
tions. The kinetic parameters are summarized in Table 1. The
ratio of dideoxynucleoside triphosphates incorporation eﬃ-
ciency of HIV-1 RT in the presence of spermine relative to that
of the enzyme alone, demonstrates 33-fold and 21-fold de-
crease in the eﬃciency of ddATP or ddTTP incorporation,
respectively.
3.3. Eﬀect of polyamines on the interaction of HIV-1 RT with
DNA substrate
During DNA synthesis the binding of HIV-1 RT to the tem-
plate-primer precedes its binding to nucleoside triphosphate
substrates. HIV-1 RT binds DNA with no apparent sequence
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5’-p32 ATT  TCA  CAT  CTG  ACT  T   -3’
3’ -CC TAA  AGT  GTA  GAC  TGA  ATT GTTTGG CGG A -5’
0 0
0.050.05
0.10.1
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- Spermine + Spermine
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Fig. 3. Kinetics of incorporation of ddATP by HIV-1 RT in the presence of spermine. The standing-start substrate (set I) was incubated with HIV-1
RT and increasing concentrations of ddATP in the absence or presence of spermine. Each reaction contained 0, 0.05, 0.1, 1.0 or 2 mM ddATP, as the
only dideoxynucleoside triphosphate substrate. PAGE analysis of the extended primers are shown in the upper panel. The quantitation of the primers
extended was plotted in the lower panel after scanning the autoradiograms.
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ence the binding of the RT to the template-primer. The addi-
tion of nucleoside analogs, e.g. AZT-TP or ddTTP had no
apparent eﬀect on the stability of the complex. We have inves-
tigated the interaction of HIV-1 RT with dsDNA in the pres-
ence of polyamines. The gel retardation assay was utilized to
examine the eﬀect of polyamines (putrescine, spermidine or
spermine) on the enzyme–DNA interaction. The results of
the experiment depicted in Fig. 5, demonstrates complex for-
mation between HIV-1 RT and DNA by the electrophoretic
retardation of the DNA, as a result of its association with
the enzyme (lane 2). When the reactions were performed in
the presence of 5 mM putrescine (lane 3), spemidine (lane 4)
or spermine (lane 5), there was no signiﬁcant change in the
intensity of the bands corresponding RT–DNA complex.4. Discussion
The eﬀectiveness of the NRTI therapy depends on (i) the up-
take of the NA into the cell; (ii) the conversion of the NA to
the triphosphate form; (iii) the incorporation of the NA into
the DNA; and (iv) the removal of the incorporated chain ter-
minator [8]. The focus of our present comparative study was to
assess the incorporation of various dideoxynucleoside triphos-
phates by HIV-1 RT in the presence of polyamines using an
in vitro reconstituted system. The results obtained suggest that
polyamines possess the potential to reduce the number of var-
ious dideoxynucleoside triphosphates incorporated at the 3 0-termini in DNA that block elongation by HIV-1 RT during
both RNAﬁ DNA and DNAﬁ DNA polymerization steps.
HIV-1 RT could be sensitive to changes in the polyamines con-
centration. Indeed polyamines exert a concentration-depen-
dent reduction eﬀect. The degree of reduction correlates with
cationic charge; divalent putrescine is least eﬀective, whereas
tetravalent spermine is more potent than trivalent spermidine.
Remarkably, spermine was detected as a major natural intra-
cellular compound protecting DNA from free radical attack
[25]. The current study shows that the polyamines display
the ability to reduce the incorporation of nucleoside analogs
by HIV-1 RT in the following order: spermine > spermi-
dine > putrescine. An important biochemical factor is the
degree by which accessory factors aﬀect the NA incorporation
process during DNA synthesis. The comparative data pre-
sented in Table 1 indicate 33-fold for ddATP and 21-fold for
ddTTP reduction in the eﬃciency of incorporation by the en-
zyme in the presence of spermine. Notably, the incorporation
of ddATP (purine NA) seems to be better suppressed by
spermine than the incorporation of ddTTP (pyrimidine NA).
Additional studies are needed to further evaluate whether the
extent of inﬂuence of the polyamines on the incorporation of
NA depends on the nature of NA (purine vs pyrimidine).
The ﬁrst step in DNA synthesis involves physical binding of
the enzyme to the DNA substrate, followed by binding of the
appropriate dNTP to the RT–DNA complex and subsequent
incorporation of the nucleotide. We have shown by gel retar-
dation assay, that polyamines have no substantial inﬂuence
on the formation or stability of the RT–DNA complex, which
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Fig. 4. Kinetics of incorporation of ddTTP by HIV-1 RT in the presence of spermine. The standing-start substrate (set II) was incubated with HIV-1
RT and increasing concentrations of ddTTP in the absence or presence of spermine. Each reaction contained 0, 0.05, 0.1, 1.0 or 2 mM ddTTP, as the
only dideoxynucleoside triphosphate substrate. PAGE analysis of the extended primers are shown in the upper panel. The quantitation of the primers
extended was plotted in the lower panel after scanning the autoradiograms. The primer position is indicated by arrow.
Table 1
Kinetics of incorporation of ddATP and ddTTP by HIV-1 RT in the absence and presence of spermine
Nucleoside analog incorporated Wild-type HIV-1 RT Wild-type HIV-1 RT in the presence of 5 mM
spermine
Km (mM) Vmax (%/min) Vmax/Km Km (mM) Vmax (%/min) Vmax/Km
ddATP 0.4 ± 0.03 2.0 ± 0.17 5 0.78 ± 0.072 0.12 ± 0.09 0.15
ddTTP 0.21 ± 0.03 2.5 ± 0.3 12 0.52 ± 0.06 0.3 ± 0.04 0.57
The kinetic Km and Vmax values were determined from Figs. 3 and 4, as described in Materials and Methods. The relative nucleoside analog
incorporation eﬃciency are ratios of rate constant (Vmax/Km) for the incorporation of nucleoside analog by the HIV-1 RT in the absence of spermine,
divided by the corresponding rate constant for the incorporation of nucleoside analog by the enzyme in the presence of spermine.
Lanes:   1   2   3  4   5
complex
free
Fig. 5. Eﬀect of polyamines on the complex formation between HIV-1
RT and DNA. Incubation mixtures contained 5 0-end labeled DNA/
DNA substrate (set I) (lane 1). The binding activity of HIV-1 RT was
analyzed in the absence (lane 2) and presence of 5 mM of putrescine
(lane 3), spermidine (lane 4) or spermine (lane 5). Arrows to the left of
the ﬁgure indicate the migration positions of the enzyme-DNA
complex (complex) and the DNA substrate alone (free).
5368 M. Bakhanashvili, G. Rahav / FEBS Letters 580 (2006) 5363–5370is the ﬁrst step in DNA polymerization (Fig. 5). Direct binding
of polyamines to DNA and their ability to modulate DNA–
protein interactions appear to be important in the molecular
mechanisms of polyamine action [14]. Apparently, polyamines
inhibit the incorporation of nucleoside analogs during subse-
quent steps in DNA polymerization.
The incorporation sites of various dideoxynucleoside tri-
phosphates tested were located at diﬀerent sequence contexts.
Our data indicate that decreased dideoxynucleoside triphos-
phates incorporation in the presence of polyamines was a gen-
eral phenomenon, taking place at all sites. Thus, the decrease
in eﬃciency of nucleoside analogs incorporation in the pres-
ence of polyamines is probably sequence-independent eﬀect.
Polymerization errors produced during DNA synthesis by
RT, which lacks a proofreading activity, are responsible for
generation of genetic variations. There might be a potential
correlation between the ﬁdelity of DNA synthesis, which in
the case of base substitution is an outcome of the ability to
incorporate a wrong nucleotide and to elongate the 3 0 mis-
M. Bakhanashvili, G. Rahav / FEBS Letters 580 (2006) 5363–5370 5369pairs, and resistance of HIV-1 RT to nucleoside analogs (the
ability of the enzyme to incorporate or reject an incoming
deoxynucleoside analog). Interestingly, the mutation rate of
HIV-1 in cells is about 15–20-fold less than that predicted by
the measured ﬁdelity of puriﬁed HIV-1 RT with the same tar-
get sequence, suggesting that the reverse transcription process
in vivo is less error-prone than in cell-free studies [26]. Further-
more, NRTIs are less potent inhibitors of HIV replication
in vivo than might be expected. It is conceivable that discrep-
ancies between the two systems may be due to several endog-
enous external factors, including the association of viral and/
or cellular accessory proteins/factors that can aﬀect the reverse
transcription process, its inhibition by NRTIs and resistance to
this inhibition in the cytoplasm of infected cells. The HIV-1
Vpr protein was proven to be an example of viral accessory
protein that inﬂuences the in vivo mutation rate (decreases
up to 5-fold) [27]. Cellular tumor suppressor protein p53 in
cytoplasm may functionally interact with HIV-1 RT, acting
as an external proofreader for mispairs (thus increasing the
ﬁdelity of DNA synthesis by HIV-1 RT) [28] and chain termi-
nators incorporated during proviral DNA synthesis (thus
reducing the eﬃciency of anti-HIV drugs) [29]. p53 by its
intrinsic exonuclease activity, probably represents the cellular
component that may have an impact on the development of
resistance to anti-retroviral compounds. Recent studies sug-
gested that the diﬀerences in the intracellular free Mg2+ con-
centrations between diﬀerent cell types or during the cell
cycle might strongly aﬀect HIV-1 replication and its inhibition
[30]. In mammalian cells polyamines together with magnesium
ions account for the majority of the intracellular cationic
charges. Our recent studies revealed that polyamines could im-
prove the replication ﬁdelity of HIV-1 RT [12]. The fact that
polyamines may enhance the accuracy of HIV-1 RT and
may decrease the amount of incorporated NAs, suggests that
the ﬁdelity of DNA synthesis by the enzyme and the inhibition
by NAs may be aﬀected by alterations in composition of the
replication complex. The viral or cellular factors/proteins
might have a relatively transient interaction with the reverse
transcription complex during various steps in the replication
process (interaction with the viral nucleic acid or with RT).
The natural polyamines are found in every living cell in micro-
molar to millimolar quantities. Cellular polyamines are regu-
lated by a complex circuitry of synthesis, degradation as well
as cellular uptake and eﬄux [14]. The increased intracellular
polyamine levels have been observed in patients infected with
HIV-1 [20]. It is not clear whether the increase in polyamines
is a direct or indirect result of HIV-1 infection. The diﬀerence
in polyamine intake as well as changes in the environment for
polyamine synthesis aﬀects polyamine levels. We suggest that
alterations in polyamines levels within the cells may aﬀect
the accuracy of the reverse transcription process and its inhibi-
tion by nucleoside analogs in viral target cells.
The development of viral resistance to anti-retroviral drugs
used in the treatment of HIV infection is a signiﬁcant cause
of therapy failure [31–34]. The low ﬁdelity of reverse transcrip-
tion can lead to changes resulting in the synthesis of new RT
molecules resistant to antiviral drugs. It is conceivable that
mutants are capable of developing diminished susceptibility
to NRTIs by several mechanisms [8]. Some of these mecha-
nisms are associated with an elevation in the accuracy of
DNA synthesis by HIV-1 RT. A possible non-viral mechanism
that achieves resistance to NRTI would be the reduction in theincorporation of NRTI or the removal of nucleoside analog
once it has been incorporated at the 3 0 end of the primer by
external cellular protein/factor, e.g. proofreading by 3 0 ﬁ 5 0
exonuclease activity of cytoplasmic p53 [28,29]. The failure
of the HIV-1 RT to incorporate NA in the presence of polyam-
ines may reduce the sensitivity to treatment in vivo. Thus, the
increase in the accuracy of DNA synthesis by HIV-1 RT in the
presence of polyamines [12] and the reduction in the amount of
incorporated NAs at the 3 0 end of the primer, suggest that
polyamines could confer a cellular resistance mechanism to
the antiviral compounds. In view of the signiﬁcance of muta-
tions of HIV-1 RT to resistance to therapeutic agents, the pos-
sible eﬀects of polyamines on incorporation of wrong
nucleotides and nucleoside analogs could be of particular
importance. Further studies are important for the understand-
ing of the resistance developed with wild-type and mutant
HIV-1 RTs, which is an important issue for the successful
treatment of HIV treatment.Acknowledgements:We are deeply thankful to Prof. A. Hizi for supply
of puriﬁed HIV-1 RT. The authors thank to Novitsky Elena for excel-
lent technical assistance.References
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